Warning: Counterfeit versions of the medicinal product Tertensif® found in Bulgaria
The Danish Medicines Agency recently posted the following alert:
Counterfeit versions of the medicinal
product Tertensif® (indapamide) 1.5 mg
enteric-coated tablets have been found at
pharmacies and distributors on the Bulgarian
market.
The counterfeit medicinal product,
Tertensif® (indapamide), 1.5 mg
enteric-coated tablets, is sold in a package
containing 30 enteric-coated tablets. The
following is printed on the packages:
Batch number: |
Package number: |
Expiry date: |
752995 |
02.2006 |
02.2008 |
5K9015 |
10.2005 |
10.2007 |
The packages are counterfeit, and thus
they are neither manufactured nor marketed by
the company that manufactures the original
medicinal product. The outer packaging and
package leaflet of the counterfeit medicinal
product is different from that of the
original medicinal product.
The counterfeit medicinal product has not
been distributed to Denmark . However, the
Danish Medicines Agency cannot rule out that
private individuals may be able to buy the
medicinal product in another way, for
instance over the internet or by private
import from a pharmacy in Bulgaria .
Persons who have used the tablets are
encouraged to stop using them and possibly
consult their general practitioner.
Moreover, the Danish Medicines Agency
would like to encourage people who have used
the counterfeit medicinal product to hand
over the remains to a pharmacy.
For further information, please contact Mikkel Walmar.
About The SafeMeds Alert System
The SafeMeds Alert System is a counterfeit alert
distribution service of the the Partnership
for Safe
Medicines--a group of
organizations and individuals that have policies,
procedures, or programs to protect consumers from
counterfeit or contraband medicines.